Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales

• Main Authors: M. Ávila-Núñez (Author), O. Lima (Author), A. Sousa (Author), M. Represa (Author), P. Rubiñán (Author), P. Celestino (Author), M. Garrido-Ventín (Author), L. García-Formoso (Author), F. Vasallo-Vidal (Author), L. Martinez-Lamas (Author), A. Pérez-Landeiro (Author), M Rubianes (Author), MT. Pérez-Rodríguez (Author)
• Format: Book
• Published: BMC, 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Carbapenems (CR) have traditionally been the first line treatment for bacteremia caused by AmpC-producing Enterobacterales. However, CR have a high ecological impact, and carbapenem-resistant strains continue rising. Thus, other treatment alternatives like Piperacillin-Tazobact...